ArticleAntimicrobial agents and chemotherapy1998
In vitro susceptibility of Coxiella burnetii to trovafloxacin in comparison with susceptibilities to pefloxacin, ciprofloxacin, ofloxacin, doxycycline, and clarithromycin.
Article in Antimicrobial agents and chemotherapy, 1998. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 29 citations in OpenAlex.
- Efficacy of rifapentine and other rifamycins againstMicrobiology spectrum · 2024Article
- The microbiota changes of the brown dog tick,Frontiers in physiology · 2022Article
- Neurotransmitter System-Targeting Drugs Antagonize Growth of the Q Fever Agent, Coxiella burnetii, in Human Cells.mSphere · 2021Article
- Antimicrobial Resistance inMicrobiology spectrum · 2018Article
- From Q Fever to Coxiella burnetii Infection: a Paradigm Change.Clinical microbiology reviews · 2017Review
- Development of Liposomal Ciprofloxacin to Treat Lung Infections.Pharmaceutics · 2016Review
- Efficacy of liposome-encapsulated ciprofloxacin in a murine model of Q fever.Antimicrobial agents and chemotherapy · 2014Article
- Antimicrobial therapies for Q fever.Expert review of anti-infective therapy · 2013Review
- Bacteriostatic and bactericidal activities of tigecycline against Coxiella burnetii and comparison with those of six other antibiotics.Antimicrobial agents and chemotherapy · 2009Article
- Correlation between ratio of serum doxycycline concentration to MIC and rapid decline of antibody levels during treatment of Q fever endocarditis.Antimicrobial agents and chemotherapy · 2005Article
- Evaluation of Coxiella burnetii antibiotic susceptibilities by real-time PCR assay.Journal of clinical microbiology · 2003Article
- Use of macrolides for Q fever.Antimicrobial agents and chemotherapy · 2003Article
- Newer macrolides as empiric treatment for acute Q fever infection.Antimicrobial agents and chemotherapy · 2001Article
- In vitro susceptibility of Coxiella burnetii to linezolid in comparison with its susceptibilities to quinolones, doxycycline, and clarithromycin.Antimicrobial agents and chemotherapy · 2001Article
- Bacteriostatic and bactericidal activities of moxifloxacin against Coxiella burnetii.Antimicrobial agents and chemotherapy · 2001Article
- Q fever during pregnancy: an emerging cause of prematurity and abortion.Infectious diseases in obstetrics and gynecology · 2001Article
- Diagnosis of quinolone-resistant Coxiella burnetii strains by PCR-RFLP.Journal of clinical laboratory analysis · 2000Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The antibiotic susceptibilities of eight Greek isolates of Coxiella burnetii to trovafloxacin were determined by the shell vial assay. MICs of trovafloxacin and ofloxacin ranged from 1 to 2 microg/ml, those of pefloxacin ranged from 1 to 4 microg/ml, those of ciprofloxacin ranged from 4 to 8 microg/ml, those of doxycycline ranged from 1 to 2 microg/ml, and those of clarithromycin ranged from 2 to 4 microg/ml. Trovafloxacin exhibited no activity against C. burnetii at 4 microg/ml.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.